Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;73(1):9-12.
doi: 10.1007/s12262-010-0121-5. Epub 2010 Dec 14.

Hormone receptor status of breast cancer in the himalayan region of northern India

Rashmi Kaul  1 , Jaishree Sharma, Satinder S Minhas, Kavita Mardi
Affiliations

Hormone receptor status of breast cancer in the himalayan region of northern India

Rashmi Kaul et al. Indian J Surg. 2011 Jan.

Abstract

The role of hormone receptors as a prognostic and therapeutic tool in breast cancer is widely accepted. The frequency of nonreactivity of estrogen and progesterone receptors in breast cancer patients of India is much more common than in the West. This study was conducted with the aim of analysis of steroid receptor status in breast cancer with clinico-pathological characteristics from the northern hilly state of Himachal Pradesh, India located in the region of the Western Himalayas. Fifty five consecutive patients with the diagnosis of breast cancer were included in this study. Detailed clinical and histopathologic data was recorded in all cases. Estrogen receptor and progesterone receptor status was evaluated by immunohistochemistry. Chi-square test was used for statistical analysis. On immunohistochemical staining, 34.5% cases proved to be estrogen receptor positive and 36.4% cases progesterone receptor positive. The results in the present study documented low estrogen receptor and progesterone receptor positivity in breast cancer from this region of India.

Keywords: Breast cancer; Steroid receptor; Western Himalayas.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Estrogen receptor immunostain showing strong nuclear positivity in tumor cells. (400X)
Fig. 2
Fig. 2
Progesterone receptor immunostain showing strong nuclear positivity in tumor cells. (400X)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast. 2000;9:267–270. doi: 10.1054/brst.2000.0134. - DOI - PubMed
    1. Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007;9:R6. doi: 10.1186/bcr1639. - DOI - PMC - PubMed
    1. Mandal AK. Hormone receptors in breast carcinoma. Indian J Pathol Microbiol. 1995;38:109–118. - PubMed
    1. Leake R. Comment. Breast. 2000;9:270.
    1. Raina V, Bhutani M, Bedi R, Sharma A, Deo SVS, Shukla NK. Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer. 2005;42:40–45. doi: 10.4103/0019-509X.15099. - DOI - PubMed

LinkOut - more resources